{"component": "definition", "props": {"groups": [{"snippet": "means two (2) times the Actual Award.", "size": 4, "samples": [{"hash": "dXSBKZflu3I", "uri": "/contracts/dXSBKZflu3I#royalty-cap", "label": "Epilepsy Foundation Award Agreement", "score": 28.0102672577, "published": true}, {"hash": "lHw8rWQzMG7", "uri": "/contracts/lHw8rWQzMG7#royalty-cap", "label": "Award Agreement", "score": 27.4175224304, "published": true}, {"hash": "lPSyRnz1PmM", "uri": "/contracts/lPSyRnz1PmM#royalty-cap", "label": "Commercialization Grant Agreement", "score": 25.7227916718, "published": true}], "snippet_links": [{"key": "actual-award", "type": "definition", "offset": [24, 36]}], "hash": "b278a3a755086409b140703fdd0cfa56", "id": 1}, {"snippet": "shall have the meaning set forth in \u00a74.1 (a).", "size": 4, "samples": [{"hash": "bdQrIZixZNz", "uri": "/contracts/bdQrIZixZNz#royalty-cap", "label": "Research Agreement (Karyopharm Therapeutics Inc.)", "score": 24.7563304901, "published": true}, {"hash": "eTo96hBljAt", "uri": "/contracts/eTo96hBljAt#royalty-cap", "label": "Research Agreement (Karyopharm Therapeutics Inc.)", "score": 24.6769332886, "published": true}], "snippet_links": [], "hash": "4f5a53470612b72d428f3e9babbc0cd7", "id": 2}, {"snippet": "means Forty Million United States Dollars (US$40,000,000).", "size": 3, "samples": [{"hash": "aB4rq2JztNM", "uri": "/contracts/aB4rq2JztNM#royalty-cap", "label": "Termination Agreement", "score": 31.3408622742, "published": true}, {"hash": "layIQjcDrux", "uri": "/contracts/layIQjcDrux#royalty-cap", "label": "Termination Agreement (Kalobios Pharmaceuticals Inc)", "score": 26.3552360535, "published": true}, {"hash": "cTV1myUZlbk", "uri": "/contracts/cTV1myUZlbk#royalty-cap", "label": "Termination Agreement (Kalobios Pharmaceuticals Inc)", "score": 25.8459949493, "published": true}], "snippet_links": [{"key": "united-states-dollars", "type": "clause", "offset": [20, 41]}], "hash": "e753df3602a6106bf4a156fc55d15c8d", "id": 3}, {"snippet": "means the aggregate maximum royalties to be paid by Discovery Labs to Battelle for performance of its obligations under the Project Plan during the Term of this Agreement. The amount of the Royalty Cap is set forth in Section 3.D(ii).", "size": 3, "samples": [{"hash": "cvYcLwXWF48", "uri": "/contracts/cvYcLwXWF48#royalty-cap", "label": "Collaboration Agreement (Windtree Therapeutics Inc /De/)", "score": 31.8747425079, "published": true}, {"hash": "2Qge2TUTjdV", "uri": "/contracts/2Qge2TUTjdV#royalty-cap", "label": "Collaboration Agreement (Discovery Laboratories Inc /De/)", "score": 23.848733902, "published": true}, {"hash": "gZ2tUmnpWn1", "uri": "https://ir.windtreetx.com/static-files/13a05775-c8f3-43d0-994f-0c5c0e0b67a4", "label": "ir.windtreetx.com", "score": 10.0253248215, "published": false}], "snippet_links": [{"key": "maximum-royalties", "type": "clause", "offset": [20, 37]}, {"key": "for-performance", "type": "clause", "offset": [79, 94]}, {"key": "the-project-plan", "type": "clause", "offset": [120, 136]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [137, 170]}, {"key": "the-royalty", "type": "clause", "offset": [186, 197]}], "hash": "f47a7aef58ff880d08a7fed1f3636777", "id": 4}, {"snippet": "means Twenty-Five Million Dollars or such lesser amount as provided in Section 3.4(b)(iii).", "size": 2, "samples": [{"hash": "b6okJiOQIXL", "uri": "/contracts/b6okJiOQIXL#royalty-cap", "label": "License and Development Agreement", "score": 31.3408622742, "published": true}, {"hash": "fwUGkgAzszf", "uri": "/contracts/fwUGkgAzszf#royalty-cap", "label": "License and Development Agreement (Cardiomems Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "lesser-amount", "type": "definition", "offset": [42, 55]}], "hash": "246fe01a6c55b815378e429c86c123e1", "id": 5}, {"snippet": "means [***] of (a) the Purchase Price, if the Buyer receives a valid Tranche 2 Election prior to or on August 31, 2024 or (b) the Tranche 1 Purchase Price, if the Buyer does not receive a valid Tranche 2 Election prior to or on August 31, 2024.", "size": 2, "samples": [{"hash": "lLbkgIL5BRR", "uri": "/contracts/lLbkgIL5BRR#royalty-cap", "label": "Purchase and Sale Agreement (Avadel Pharmaceuticals PLC)", "score": 34.2402458191, "published": true}, {"hash": "bcO2X2HOSbx", "uri": "https://investors.avadel.com/static-files/bec4f0d0-1a3b-48f8-b6f3-fedbe313b0cd", "label": "investors.avadel.com", "score": 11.7008895874, "published": false}], "snippet_links": [{"key": "the-purchase-price", "type": "clause", "offset": [19, 37]}, {"key": "if-the-buyer", "type": "clause", "offset": [39, 51]}, {"key": "tranche-2", "type": "definition", "offset": [69, 78]}, {"key": "prior-to", "type": "definition", "offset": [88, 96]}, {"key": "tranche-1-purchase-price", "type": "definition", "offset": [130, 154]}], "hash": "59b65570453c6a9598c062e5d608d5c7", "id": 6}, {"snippet": "Shall have the meaning set forth in Section 6.4;", "size": 2, "samples": [{"hash": "3RmYKtuJALp", "uri": "/contracts/3RmYKtuJALp#royalty-cap", "label": "Strategic Licensing, Distribution and Marketing Agreement (Pacira Pharmaceuticals, Inc.)", "score": 22.032169342, "published": true}, {"hash": "iKe9k4opeFz", "uri": "/contracts/iKe9k4opeFz#royalty-cap", "label": "Strategic Licensing, Distribution and Marketing Agreement (Pacira Pharmaceuticals, Inc.)", "score": 21.9199180603, "published": true}], "snippet_links": [{"key": "section-64", "type": "clause", "offset": [36, 47]}], "hash": "ede2a6db02be9c14a9051a92fabd2a7d", "id": 7}, {"snippet": "means $725,000,000.", "size": 2, "samples": [{"hash": "eHf3dA2cOyU", "uri": "/contracts/eHf3dA2cOyU#royalty-cap", "label": "Royalty Purchase Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 33.5722122192, "published": true}, {"hash": "iqSOW9Q7SHp", "uri": "https://ir.ultragenyx.com/static-files/44700912-6bd4-4593-b2a8-72bf0aac2e57", "label": "ir.ultragenyx.com", "score": 11.2861051559, "published": false}], "snippet_links": [], "hash": "8f5e006928cfe53a1ae760643009ba6f", "id": 8}, {"snippet": "means ___________ ( ) times the Actual Award.", "size": 2, "samples": [{"hash": "7Cor0H99b3e", "uri": "/contracts/7Cor0H99b3e#royalty-cap", "label": "Foundation Agreement", "score": 31.7578544617, "published": true}], "snippet_links": [{"key": "actual-award", "type": "definition", "offset": [32, 44]}], "hash": "7cec7212e1d70c17926a12b14b066734", "id": 9}, {"snippet": "shall have the meaning set forth in Section 9.3.", "size": 2, "samples": [{"hash": "6rqDagzZNHJ", "uri": "/contracts/6rqDagzZNHJ#royalty-cap", "label": "Research Funding Agreement (Affimed Therapeutics B.V.)", "score": 25.4846000671, "published": true}], "snippet_links": [{"key": "section-93", "type": "clause", "offset": [36, 47]}], "hash": "de656640198dd79d6807ed2a8ffd8827", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUcm95YWx0eS1jYXAjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means two (2) times the Actual Award.", "size": 58, "title": "Royalty Cap", "id": "royalty-cap", "examples": ["Once cumulative royalty payments to Seller equal the <strong>Royalty Cap</strong>, no further royalty shall be owed.", "The aggregate royalty payments under this Section 3.2 shall not exceed the <strong>Royalty Cap</strong>."], "related": [["royalty-rate", "Royalty Rate", "Royalty Rate"], ["royalty-payments", "Royalty Payments", "Royalty Payments"], ["royalty-fee", "Royalty Fee", "Royalty Fee"], ["royalty-year", "Royalty Year", "Royalty Year"], ["sublicense-revenue", "Sublicense Revenue", "Sublicense Revenue"]], "related_snippets": [], "updated": "2026-05-16T04:22:31+00:00"}, "json": true, "cursor": ""}}